Cindy L Ehlers1, Ian R Gizer. 1. Department of Molecular and Integrative Neurosciences, the Scripps Research Institute, La Jolla, CA, USA. cindye@scripps.edu
Abstract
OBJECTIVE: Although tribes differ with regard to the use of alcohol and drugs, substance dependence is one of the primary sources of health problems facing Native Americans. General population studies have demonstrated that substance dependence has a substantially heritable component (approximately 50% of the risk resulting from genetic influences); however, fewer studies have investigated the role of genetics in the risk for substance dependence in Native Americans. METHOD: The authors present a literature review of the evidence for a genetic component in the etiology of substance dependence in Native Americans, including studies of heritability, linkage analyses, and candidate genes. RESULTS: Evidence for the heritability of alcohol and drug dependence was found. Linkage analyses revealed that genes influencing risk for substance dependence and related phenotypes, such as body mass index (BMI), drug tolerance, EEG patterns, and externalizing traits, reside on several chromosome regions identified in other population samples. Overlap in the gene locations for substance dependence and BMI suggests that a common genetic substrate may exist for disorders of consumption. Studies of the genes that code for alcohol-metabolizing enzymes have not revealed any risk variants specific to Native American populations, although most Native Americans lack protective variants seen in other populations. Other candidate genes associated with substance dependence phenotypes in Native Americans include OPRM1, CRN1, COMT, GABRA2, MAOA, and HTR3-B. CONCLUSIONS: Substance dependence has a substantial genetic component in Native Americans, similar in magnitude to that reported for other populations. The high rates of substance dependence seen in some tribes is likely a combination of a lack of genetic protective factors (metabolizing enzyme variants) combined with genetically mediated risk factors (externalizing traits, consumption drive, and drug sensitivity or tolerance) that combine with key environmental factors (trauma exposure, early age at onset of use, and environmental hardship) to produce an elevated risk for the disorder.
OBJECTIVE: Although tribes differ with regard to the use of alcohol and drugs, substance dependence is one of the primary sources of health problems facing Native Americans. General population studies have demonstrated that substance dependence has a substantially heritable component (approximately 50% of the risk resulting from genetic influences); however, fewer studies have investigated the role of genetics in the risk for substance dependence in Native Americans. METHOD: The authors present a literature review of the evidence for a genetic component in the etiology of substance dependence in Native Americans, including studies of heritability, linkage analyses, and candidate genes. RESULTS: Evidence for the heritability of alcohol and drug dependence was found. Linkage analyses revealed that genes influencing risk for substance dependence and related phenotypes, such as body mass index (BMI), drug tolerance, EEG patterns, and externalizing traits, reside on several chromosome regions identified in other population samples. Overlap in the gene locations for substance dependence and BMI suggests that a common genetic substrate may exist for disorders of consumption. Studies of the genes that code for alcohol-metabolizing enzymes have not revealed any risk variants specific to Native American populations, although most Native Americans lack protective variants seen in other populations. Other candidate genes associated with substance dependence phenotypes in Native Americans include OPRM1, CRN1, COMT, GABRA2, MAOA, and HTR3-B. CONCLUSIONS: Substance dependence has a substantial genetic component in Native Americans, similar in magnitude to that reported for other populations. The high rates of substance dependence seen in some tribes is likely a combination of a lack of genetic protective factors (metabolizing enzyme variants) combined with genetically mediated risk factors (externalizing traits, consumption drive, and drug sensitivity or tolerance) that combine with key environmental factors (trauma exposure, early age at onset of use, and environmental hardship) to produce an elevated risk for the disorder.
Authors: Jordi Clarimon; Rebecca R Gray; Lindsey N Williams; Mary-Anne Enoch; Robert W Robin; Bernard Albaugh; Andrew Singleton; David Goldman; Connie J Mulligan Journal: Alcohol Clin Exp Res Date: 2007-04 Impact factor: 3.455
Authors: Jacquelyn L Meyers; Jian Zhang; Niklas Manz; Madhavi Rangaswamy; Chella Kamarajan; Leah Wetherill; David B Chorlian; Sun J Kang; Lance Bauer; Victor Hesselbrock; John Kramer; Samuel Kuperman; John I Nurnberger; Jay Tischfield; Jen Chyong Wang; Howard J Edenberg; Alison Goate; Tatiana Foroud; Bernice Porjesz Journal: Int J Psychophysiol Date: 2016-12-28 Impact factor: 2.997
Authors: C L Ehlers; I R Gizer; C Bizon; W Slutske; Q Peng; N J Schork; K C Wilhelmsen Journal: Genes Brain Behav Date: 2016-06-01 Impact factor: 3.449
Authors: J L Meyers; J Zhang; J C Wang; J Su; S I Kuo; M Kapoor; L Wetherill; S Bertelsen; D Lai; J E Salvatore; C Kamarajan; D Chorlian; A Agrawal; L Almasy; L Bauer; K K Bucholz; G Chan; V Hesselbrock; L Koganti; J Kramer; S Kuperman; N Manz; A Pandey; M Seay; D Scott; R E Taylor; D M Dick; H J Edenberg; A Goate; T Foroud; B Porjesz Journal: Mol Psychiatry Date: 2017-01-10 Impact factor: 15.992
Authors: Sarah E Zemore; Katherine J Karriker-Jaffe; Nina Mulia; William C Kerr; Cindy L Ehlers; Won Kim Cook; Priscilla Martinez; Camillia Lui; Thomas K Greenfield Journal: J Stud Alcohol Drugs Date: 2018-01 Impact factor: 2.582